‘An especially exciting feature to this discovery is usually that the essential cancer-causing event involves a kinase – – NIK – – and a protease – – API2-MALT1. Both kinases and proteases are considered druggable, indicating they are potential targets for developing drugs that block their activity,’ says Lucas, assistant professor of pathology at the U-M Medical College. MALT lymphomas that carry the API2-MALT1 fusion protein tend to be aggressive and even more resistant to treatment.Westrick received her BSPharm from Chulalongkorn University , her MS in Industrial Technology from Illinois Condition University, and her PhD in Administrative and Interpersonal Sciences in Pharmacy from the University of Wisconsin-Madison. Her research experience includes organizational plan and change evaluation, with significant work related to the adoption, sustainability, and abandonment of pharmacy-structured immunization services. She has served as the business lead researcher for the RxVaccinate project provided by APhA, and she partners with the Alabama Division of Senior Services to offer Medicare insurance coverage selection assistance for beneficiaries.